查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1301102

临床试验用品市场规模、份额和趋势分析报告：按临床阶段、按产品/服务、按最终用途、按治疗用途、按地区、细分趋势，2023-2030 年

Clinical Trial Supplies Market Size, Share & Trends Analysis Report By Clinical Phase (Phase I, Phase II, Phase III), By Product & Services, By End-Use, By Therapeutic Use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 123 Pages | 商品交期: 2-10个工作天内

价格

临床试验用品市场增长和趋势

根据 New GrandView Research, Inc. 的报告，全球临床试验用品市场规模预计从 2023 年到 2030 年将以 6.5% 的复合年增长率扩大，到 2030 年将达到 34 亿美元。

临床试验数量的增加和试验实施的复杂性的增加是推动市场增长的主要因素。

在全球范围内，慢性病患病率的上升和人口的迅速老龄化预计将推动生物製品研发的增长，进一步推动对高效临床用品的需求，并增加临床检测用品行业的增长。 此外，孤儿药需求的增加以及罕见病研发的高投入也有望促进生物製剂的发展。 由于这些因素，该细分市场可能在预测期内出现显着增长。

例如，2022年诺华公司在研发方面投入了约100亿美元。 它还在欧盟（EU）、日本、中国和美国获得了23项新药和罕见疾病的批准。 印度还有44个正在进行的III期项目，包括非典型溶血性尿毒症综合征（aHUS）、免疫性血小板减少性紫癜（ITP）、脊髓性肌萎缩症（SMA）、狼疮性肾炎等罕见疾病的临床项目17个。

直接面向患者（DTP）是有望成为未来临床试验药物分销的分销模式的一个细分市场。 DTP 是较新的模式之一，直接向患者提供药物并进行以患者为中心的试验。 这减少了访问研究地点的次数，减轻了参与者的负担。 COVID-19 的爆发导致越来越多地采用此类模型来继续临床试验研究，同时将干扰降至最低。 此外，全球范围内的患者保留率和多样化的患者库是该模型采用率高的一些主要原因。

临床试验用品市场报告要点

  • 从临床阶段来看，预计 2022 年 III 期试验将主导市场，占销售份额的 52.7%。 目前处于 III 期试验的大量分子是这种下降的主要原因。
  • 在服务中，存储和配送领域预计将增长最快，在预测期内復合年增长率为 6.8%。 全球生物製剂管道的不断增长和温度敏感药物数量的增加预计将增加临床试验药物物流的复杂性。
  • 由于遗传学和生物技术领域的研究不断增加，例如基于纳米颗粒的药物输送系统的开发，预计生物製剂在预测期内将以 6.7% 的复合年增长率增长最快。
  • 在治疗应用中，肿瘤学在 2022 年占据市场主导地位，收入份额为 38.8%。 据合众社国际报导，美国医院因管理不当而丢弃了数十亿瓶抗癌药物，凸显了适当供应管理的必要性。

内容

第一章调查方法及范围

  • 市场细分和范围
  • 区域范围
  • 估计/预测时间表
  • 目的
  • 调查方法
  • 信息获取
  • 信息或数据分析
  • 市场形成和验证
  • 型号详细信息
  • 辅助信息列表
  • 缩写列表

第 2 章执行摘要

  • 市场前景
  • 分部展望
  • 竞争考虑因素

第 3 章临床试验用品市场变量、趋势和范围

  • 市场体系展望
    • 母公司市场前景
    • 相关/补充市场前景
  • 市场动态
    • 市场驱动因素分析
    • 市场製约因素分析
  • 临床试验用品市场分析工具
    • 行业分析-波特分析
    • PESTEL 分析
    • COVID-19 感染的影响分析

第四章临床试验用品市场：临床阶段估计和趋势分析

  • 临床试验用品市场（按临床阶段）：细分仪表板
  • 临床试验用品市场（按临床阶段）：变异分析
    • 第一阶段
    • 第二阶段
    • 第三阶段
    • 第四阶段
    • 其他

第五章临床试验用品市场：产品和服务的估算和趋势分析

  • 临床试验用品市场（按产品和服务）：细分仪表板
  • 临床试验用品市场（按产品和服务）：变化分析
    • 製造业
    • 存储和分发
    • 供应链管理

第六章临床试验用品市场：治疗领域预估及趋势分析

  • 临床试验用品市场，按治疗领域：细分仪表板
  • 临床试验用品市场，按治疗领域：变化分析
    • 肿瘤学
    • 中枢神经系统
    • 心血管
    • 感染
    • 代谢紊乱
    • 其他

第七章临床试验用品市场：最终用途估计和趋势分析

  • 临床试验用品市场，按最终用途：细分仪表板
  • 临床试验用品市场，按最终用途：变化分析
    • 药品
    • 生物製品
    • 医疗设备
    • 其他

第八章临床试验用品市场：区域估算和趋势分析

  • 2022 年和 2030 年区域市场份额分析
  • 区域市场仪表板
  • 全球区域市场概况
  • 北美
    • 2018-2030 年市场预估和预测（收入）
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 意大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 印度
    • 中国
    • 韩国
    • 澳大利亚
    • 泰国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • MEA
    • 南非
    • 沙特阿拉伯
    • 阿拉伯联合酋长国
    • 科威特

第 9 章竞争格局

  • 市场进入者分类
    • 创新者
    • 市场领导者
    • 新兴玩家
    • 2022 年公司市场份额分析
  • 公司简介
    • Almac Group
    • Biocair
    • Catalent, Inc.
    • KLIFO
    • Movianto
    • PCI Pharma Services
    • Sharp Services, LLC
    • Thermo Fisher Scientific, Inc.
    • Marken
    • Paraxel International Corporation
Product Code: GVR-1-68038-514-4

Clinical Trial Supplies Market Growth & Trends

The global clinical trial supplies market size is expected to reach USD 3.4 billion by 2030, expanding at 6.5% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. Increasing volume of clinical trial studies coupled with the growing complexity in conduction of these trials are some of the major factors driving the market growth.

Globally, an increase in the prevalence of chronic diseases and the rapidly aging population are expected to drive the growth of R&D of biologics, which is expected to further propel the demand for efficient clinical supplies and contribute to the growth of the clinical trial supplies industry. Furthermore, an increase in the demand for orphan drugs and high investment in the R&D of rare diseases are also expected to contribute toward the development of biologic drugs. Thus, owing to these factors, this segment is likely to witness significant growth during the forecast period.

For instance, in 2022, Novartis invested around USD 10 billion in research and development. It also secured 23 approvals in the European Union, Japan, China, and the U.S. for new drugs and rare diseases. The company is also conducting 44 ongoing phase III programs in India with 17 clinical programs running in rare diseases such as atypical hemolytic uremic syndrome (aHUS), Immune thrombocytopenic purpura (ITP), spinal muscular atrophy (SMA), and Lupus Nephritis.

Direct-to-Patients (DTP) is an upcoming segment in the distribution of clinical trial supplies, which is expected to be the future model of distribution. DTP is one of the emerging models that involves delivering drugs to patients directly to create patient-centric trials. This would facilitate fewer visits to the site and reduce the burden on participants. The COVID-19 outbreak has led to the increased adoption of such a model, to continue clinical trial studies with minimum disruption. In addition, patient retention and a diverse pool of patients worldwide are some of the notable reasons that can be attributed to the high adoption of this model.

Clinical Trial Supplies Market Report Highlights

  • Based on the clinical phase, the market is anticipated to be dominated by the Phase III trial segment with a 52.7% revenue share in 2022. The presence of a large number of molecules currently under Phase III makes it the primary factor responsible for this deduction
  • Among services, the storage, and distribution segment is anticipated to witness the fastest growth at a CAGR of 6.8% during the forecast period. The rise in global biologics pipeline and temperature-sensitive drugs is expected to increase the complexities related to the logistics of clinical trial supplies
  • Biologics are expected to witness the fastest growth at 6.7% CAGR during the forecast period owing to the increasing research in the field of genetics and biotechnology such as the development of nanoparticle-based drug delivery systems
  • In terms of therapeutic use, oncology dominated the market with a revenue share of 38.8% in 2022. According to the United Press International, hospitals in the U.S. are disposing of billions of cancer drug vials due to improper dosage, thereby indicating the need for appropriate supply management

Table of Contents

Chapter 1. Research Methodology And Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment Definitions
    • 1.1.2. Clinical Phase
    • 1.1.3. Product & Services
    • 1.1.4. End Use
    • 1.1.5. Therapeutic Area
  • 1.2. Regional Scope
  • 1.3. Estimates And Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
    • 1.4.3. Objective - 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information Or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
    • 1.9.2. Parent Market Analysis
  • 1.10. List Of Secondary Sources
  • 1.11. List Of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Clinical Trial Supplies Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Expansion of clinical trials sites
      • 3.2.1.2. Growing R&D in biologics and biosimilar
      • 3.2.1.3. Advancements in supply chain technology
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Presence of stringent regulatory policies
      • 3.2.2.2. High Possibility of Counterfeiting Drugs
  • 3.3. Clinical Trial Supplies Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Clinical Trial Supplies Market: Clinical Phase Estimates & Trend Analysis

  • 4.1. Clinical Trial Supplies Market, By Clinical Phase: Segment Dashboard
  • 4.2. Clinical Trial Supplies Market, By Clinical Phase: Movement Analysis
  • 4.3. Clinical Trial Supplies Market Estimates & Forecasts, By Clinical Phase, 2018 - 2030
    • 4.3.1. Phase I
      • 4.3.1.1. Phase I Clinical Trial Supplies Market, 2018 to 2030 (USD Billion)
    • 4.3.2. Phase II
      • 4.3.2.1. Phase II Clinical Trial Supplies Market, 2018 to 2030 (USD Billion)
    • 4.3.3. Phase III
      • 4.3.3.1. Phase III Clinical Trial Supplies Market, 2018 to 2030 (USD Billion)
    • 4.3.4. Phase IV
      • 4.3.4.1. Phase IV Clinical Trial Supplies Market, 2018 to 2030 (USD Billion)
    • 4.3.5. Others
      • 4.3.5.1. Others market, 2018 to 2030 (USD Billion)

Chapter 5. Clinical Trial Supplies Market: Product & Service Estimates & Trend Analysis

  • 5.1. Clinical Trial Supplies Market, By Product & Service: Segment Dashboard
  • 5.2. Clinical Trial Supplies Market, By Product & Service: Movement Analysis
  • 5.3. Clinical Trial Supplies Market Estimates & Forecasts, By Product & Service, 2018 - 2030
    • 5.3.1. Manufacturing
      • 5.3.1.1. Manufacturing Clinical Trial Supplies Market, 2018 to 2030 (USD Billion)
    • 5.3.2. Storage & Distribution
      • 5.3.2.1. Storage & Distribution Clinical Trial Supplies Market, 2018 to 2030 (USD Billion)
    • 5.3.3. Supply Chain Management
      • 5.3.3.1. Supply Chain Management Clinical Trial Supplies Market, 2018 to 2030 (USD Billion)

Chapter 6. Clinical Trial Supplies Market: Therapeutic Area Estimates & Trend Analysis

  • 6.1. Clinical Trial Supplies Market, By Therapeutic Area: Segment Dashboard
  • 6.2. Clinical Trial Supplies Market, By Therapeutic Area: Movement Analysis
  • 6.3. Clinical Trial Supplies Market Estimates & Forecasts, By Therapeutic Area, 2018 - 2030
    • 6.3.1. Oncology
      • 6.3.1.1. Oncology clinical trial supplies market 2018 to 2030 (USD Billion)
    • 6.3.2. CNS
      • 6.3.2.1. CNS clinical trial supplies market 2018 to 2030 (USD Billion)
    • 6.3.3. Cardiovascular
      • 6.3.3.1. Cardiovascular clinical trial supplies market 2018 to 2030 (USD Billion)
    • 6.3.4. Infectious disease
      • 6.3.4.1. Infectious disease clinical trial supplies market 2018 to 2030 (USD Billion)
    • 6.3.5. Metabolic disorders
      • 6.3.5.1. Metabolic Disorders Clinical Trial Supplies Market, 2018 to 2030 (USD Billion)
    • 6.3.6. Others
      • 6.3.6.1. Others clinical trial supplies market 2018 to 2030 (USD Billion)

Chapter 7. Clinical Trial Supplies Market: End-use Estimates & Trend Analysis

  • 7.1. Clinical Trial Supplies Market, By End-use: Segment Dashboard
  • 7.2. Clinical Trial Supplies Market, By End-use: Movement Analysis
  • 7.3. Clinical Trial Supplies Market Estimates & Forecasts, By End-use, 2018 - 2030
    • 7.3.1. Pharmaceutical
      • 7.3.1.1. Pharmaceutical Clinical trial supplies market 2018 to 2030 (USD Billion)
    • 7.3.2. Biologics
      • 7.3.2.1. Biologics clinical trial supplies market 2018 to 2030 (USD Billion)
    • 7.3.3. Medical Devices
      • 7.3.3.1. Medical devices clinical trial supplies market 2018 to 2030 (USD Billion)
    • 7.3.4. Others
      • 7.3.4.1. Others clinical trial supplies market 2018 to 2030 (USD Billion)

Chapter 8. Clinical Trial Supplies Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2022 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Global Regional Market Snapshot
  • 8.4. North America
    • 8.4.1. Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Billion)
    • 8.4.2. U.S.
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Competitive scenario
      • 8.4.2.3. Regulatory framework
      • 8.4.2.4. U.S. market estimates and forecasts, 2018 - 2030
    • 8.4.3. Canada
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Competitive scenario
      • 8.4.3.3. Regulatory framework
      • 8.4.3.4. Canada market estimates and forecasts, 2018 - 2030
  • 8.5. Europe
    • 8.5.1. UK
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Competitive scenario
      • 8.5.1.3. Regulatory framework
      • 8.5.1.4. UK market estimates and forecasts, 2018 - 2030
    • 8.5.2. Germany
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Competitive scenario
      • 8.5.2.3. Regulatory framework
      • 8.5.2.4. Germany market estimates and forecasts, 2018 - 2030
    • 8.5.3. France
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Competitive scenario
      • 8.5.3.3. Regulatory framework
      • 8.5.3.4. France market estimates and forecasts, 2018 - 2030
    • 8.5.4. Italy
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Competitive scenario
      • 8.5.4.3. Regulatory framework
      • 8.5.4.4. Italy market estimates and forecasts, 2018 - 2030
    • 8.5.5. Spain
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Competitive scenario
      • 8.5.5.3. Regulatory framework
      • 8.5.5.4. Spain market estimates and forecasts, 2018 - 2030
    • 8.5.6. Denmark
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Competitive scenario
      • 8.5.6.3. Regulatory framework
      • 8.5.6.4. Denmark market estimates and forecasts, 2018 - 2030
    • 8.5.7. Sweden
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Competitive scenario
      • 8.5.7.3. Regulatory framework
      • 8.5.7.4. Sweden market estimates and forecasts, 2018 - 2030
    • 8.5.8. Norway
      • 8.5.8.1. Key country dynamics
      • 8.5.8.2. Competitive scenario
      • 8.5.8.3. Regulatory framework
      • 8.5.8.4. Norway market estimates and forecasts, 2018 - 2030
  • 8.6. Asia Pacific
    • 8.6.1. Japan
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Competitive scenario
      • 8.6.1.3. Regulatory framework
      • 8.6.1.4. Japan market estimates and forecasts, 2018 - 2030
    • 8.6.2. India
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Competitive scenario
      • 8.6.2.3. Regulatory framework
      • 8.6.2.4. India market estimates and forecasts, 2018 - 2030
    • 8.6.3. China
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Competitive scenario
      • 8.6.3.3. Regulatory framework
      • 8.6.3.4. China market estimates and forecasts, 2018 - 2030
    • 8.6.4. South Korea
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Competitive scenario
      • 8.6.4.3. Regulatory framework
      • 8.6.4.4. South Korea market estimates and forecasts, 2018 - 2030
    • 8.6.5. Australia
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Competitive scenario
      • 8.6.5.3. Regulatory framework
      • 8.6.5.4. Australia market estimates and forecasts, 2018 - 2030
    • 8.6.6. Thailand
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Competitive scenario
      • 8.6.6.3. Regulatory framework
      • 8.6.6.4. Thailand market estimates and forecasts, 2018 - 2030
  • 8.7. Latin America
    • 8.7.1. Brazil
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Competitive scenario
      • 8.7.1.3. Regulatory framework
      • 8.7.1.4. Brazil market estimates and forecasts, 2018 - 2030
    • 8.7.2. Mexico
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Competitive scenario
      • 8.7.2.3. Regulatory framework
      • 8.7.2.4. Mexico Market estimates and forecasts, 2018 - 2030
    • 8.7.3. Argentina
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Competitive scenario
      • 8.7.3.3. Regulatory framework
      • 8.7.3.4. Argentina market estimates and forecasts, 2018 - 2030
  • 8.8. MEA
    • 8.8.1. South Africa
      • 8.8.1.1. Key country dynamics
      • 8.8.1.2. Competitive scenario
      • 8.8.1.3. Regulatory framework
      • 8.8.1.4. South Africa market estimates and forecasts, 2018 - 2030
    • 8.8.2. Saudi Arabia
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Competitive scenario
      • 8.8.2.3. Regulatory framework
      • 8.8.2.4. Saudi Arabia market estimates and forecasts, 2018 - 2030
    • 8.8.3. UAE
      • 8.8.3.1. Key country dynamics
      • 8.8.3.2. Competitive scenario
      • 8.8.3.3. Regulatory framework
      • 8.8.3.4. UAE market estimates and forecasts, 2018 - 2030
    • 8.8.4. Kuwait
      • 8.8.4.1. Key country dynamics
      • 8.8.4.2. Competitive scenario
      • 8.8.4.3. Regulatory framework
      • 8.8.4.4. Kuwait market estimates and forecasts, 2018 - 2030

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
    • 9.1.1. Innovators
    • 9.1.2. Market Leaders
    • 9.1.3. Emerging Players
    • 9.1.4. Company Market Share Analysis, 2022
  • 9.2. Company Profiles
    • 9.2.1. Almac Group
      • 9.2.1.1. Company overview
      • 9.2.1.2. Financial performance
      • 9.2.1.3. Service benchmarking
      • 9.2.1.4. Strategic initiatives
    • 9.2.2. Biocair
      • 9.2.2.1. Company overview
      • 9.2.2.2. Financial performance
      • 9.2.2.3. Service benchmarking
      • 9.2.2.4. Strategic initiatives
    • 9.2.3. Catalent, Inc.
      • 9.2.3.1. Company overview
      • 9.2.3.2. Financial performance
      • 9.2.3.3. Service benchmarking
      • 9.2.3.4. Strategic initiatives
    • 9.2.4. KLIFO
      • 9.2.4.1. Company overview
      • 9.2.4.2. Financial performance
      • 9.2.4.3. Service benchmarking
      • 9.2.4.4. Strategic initiatives
    • 9.2.5. Movianto
      • 9.2.5.1. Company overview
      • 9.2.5.2. Financial performance
      • 9.2.5.3. Service benchmarking
      • 9.2.5.4. Strategic initiatives
    • 9.2.6. PCI Pharma Services
      • 9.2.6.1. Company overview
      • 9.2.6.2. Financial performance
      • 9.2.6.3. Service benchmarking
      • 9.2.6.4. Strategic initiatives
    • 9.2.7. Sharp Services, LLC
      • 9.2.7.1. Company overview
      • 9.2.7.2. Financial performance
      • 9.2.7.3. Service benchmarking
      • 9.2.7.4. Strategic initiatives
    • 9.2.8. Thermo Fisher Scientific, Inc.
      • 9.2.8.1. Company overview
      • 9.2.8.2. Financial performance
      • 9.2.8.3. Service benchmarking
      • 9.2.8.4. Strategic initiatives
    • 9.2.9. Marken
      • 9.2.9.1. Company overview
      • 9.2.9.2. Financial performance
      • 9.2.9.3. Service benchmarking
      • 9.2.9.4. Strategic initiatives
    • 9.2.10. Paraxel International Corporation
      • 9.2.10.1. Company overview
      • 9.2.10.2. Financial performance
      • 9.2.10.3. Service benchmarking
      • 9.2.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
  • Table 3 North America clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
  • Table 4 North America clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
  • Table 5 North America clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
  • Table 6 US clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
  • Table 7 US clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
  • Table 8 US clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
  • Table 9 US clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
  • Table 10 Canada clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
  • Table 11 Canada clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
  • Table 12 Canada clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
  • Table 13 Canada clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
  • Table 14 Europe clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
  • Table 15 Europe clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
  • Table 16 Europe clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
  • Table 17 Europe clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
  • Table 18 UK clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
  • Table 19 UK clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
  • Table 20 UK clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
  • Table 21 UK clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
  • Table 22 Germany clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
  • Table 23 Germany clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
  • Table 24 Germany clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
  • Table 25 Germany clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
  • Table 26 France clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
  • Table 27 France clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
  • Table 28 France clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
  • Table 29 France clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
  • Table 30 Italy clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
  • Table 31 Italy clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
  • Table 32 Italy clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
  • Table 33 Italy clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
  • Table 34 Spain clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
  • Table 35 Spain clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
  • Table 36 Spain clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
  • Table 37 Spain clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
  • Table 38 Denmark clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
  • Table 39 Denmark clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
  • Table 40 Denmark clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
  • Table 41 Denmark clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
  • Table 42 Sweden clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
  • Table 43 Sweden clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
  • Table 44 Sweden clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
  • Table 45 Sweden clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
  • Table 46 Norway clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
  • Table 47 Norway clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
  • Table 48 Norway clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
  • Table 49 Norway clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
  • Table 50 Asia Pacific clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
  • Table 51 Asia Pacific clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
  • Table 52 Asia Pacific clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
  • Table 53 Asia Pacific clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
  • Table 54 Japan clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
  • Table 55 Japan clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
  • Table 56 Japan clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
  • Table 57 Japan clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
  • Table 58 China clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
  • Table 59 China clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
  • Table 60 China clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
  • Table 61 China clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
  • Table 62 India clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
  • Table 63 India clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
  • Table 64 India clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
  • Table 65 India clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
  • Table 66 Australia clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
  • Table 67 Australia clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
  • Table 68 Australia clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
  • Table 69 Australia clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
  • Table 70 South Korea clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
  • Table 71 South Korea clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
  • Table 72 South Korea clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
  • Table 73 South Korea clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
  • Table 74 Thailand clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
  • Table 75 Thailand clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
  • Table 76 Thailand clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
  • Table 77 Thailand clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
  • Table 78 Latin America clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
  • Table 79 Latin America clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
  • Table 80 Latin America clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
  • Table 81 Latin America clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
  • Table 82 Brazil clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
  • Table 83 Brazil clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
  • Table 84 Brazil clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
  • Table 85 Brazil clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
  • Table 86 Mexico clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
  • Table 87 Mexico clinical trials supply chain management market, by type, 2018 - 2030 (USD Billion)
  • Table 88 Mexico clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
  • Table 89 Mexico clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
  • Table 90 MEA clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
  • Table 91 MEA clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
  • Table 92 MEA clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
  • Table 93 MEA clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
  • Table 94 South Africa clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
  • Table 95 South Africa clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
  • Table 96 South Africa clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
  • Table 97 South Africa clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
  • Table 98 Saudi Arabia clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
  • Table 99 Saudi Arabia clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
  • Table 100 Saudi Arabia clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
  • Table 101 Saudi Arabia clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
  • Table 102 UAE clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
  • Table 103 UAE clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
  • Table 104 UAE clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
  • Table 105 UAE clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
  • Table 106 Kuwait clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
  • Table 107 Kuwait clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
  • Table 108 Kuwait clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
  • Table 109 Kuwait clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market summary (Figures in USD Billion, 2022)
  • Fig. 8 Market trends & outlook
  • Fig. 9 Clinical trial supplies market: Market segmentation
  • Fig. 10 Clinical trial supplies market revenue, (USD Billion), 2018 - 2030
  • Fig. 11 Clinical trial supplies: Porter's analysis
  • Fig. 12 Clinical trial supplies: PESTEL analysis
  • Fig. 13 Clinical trial supplies market phase outlook key takeaways
  • Fig. 14 Clinical trial supplies market: Phase movement analysis
  • Fig. 15 Phase I market, 2018 - 2030 (USD Billion)
  • Fig. 16 Phase II market, 2018 - 2030 (USD Billion)
  • Fig. 17 Phase III market, 2018 - 2030 (USD Billion)
  • Fig. 18 Others market, 2018 - 2030 (USD Billion)
  • Fig. 19 Clinical trial supplies market product/service outlook key takeaways
  • Fig. 20 Clinical trial supplies market: Product/Service movement analysis
  • Fig. 21 Manufacturing market, 2018 - 2030 (USD Billion)
  • Fig. 22 Storage & distribution market, 2018 - 2030 (USD Billion)
  • Fig. 23 Cold chain-based storage & distribution market, 2018 - 2030 (USD Billion)
  • Fig. 24 Non-cold chain-based storage & distribution market, 2018 - 2030 (USD Billion)
  • Fig. 25 Supply chain management market, 2018 - 2030 (USD Billion)
  • Fig. 26 Clinical trial supplies market end-use outlook key takeaways
  • Fig. 27 Clinical trial supplies market: End-use movement analysis
  • Fig. 28 Pharmaceuticals market, 2018 - 2030 (USD Billion)
  • Fig. 29 Biologics market, 2018 - 2030 (USD Billion)
  • Fig. 30 Medical device market, 2018 - 2030 (USD Billion)
  • Fig. 31 Other end-use market, 2018 - 2030 (USD Billion)
  • Fig. 32 Clinical trial supplies market therapeutic use outlook key takeaways
  • Fig. 33 Clinical trial supplies market: Therapeutic Use movement analysis
  • Fig. 34 Oncology market, 2018 - 2030 (USD Billion)
  • Fig. 35 CNS market, 2018 - 2030 (USD Billion)
  • Fig. 36 Cardiovascular market, 2018 - 2030 (USD Billion)
  • Fig. 37 Infectious disease market, 2018 - 2030 (USD Billion)
  • Fig. 38 Metabolic disorders market, 2018 - 2030 (USD Billion)
  • Fig. 39 Other therapeutic use market, 2018 - 2030 (USD Billion)
  • Fig. 40 Regional marketplace: Key takeaways
  • Fig. 41 North America clinical trial supplies market, 2018 - 2030 (USD Billion)
  • Fig. 42 U.S. clinical trial supplies market, 2018 - 2030 (USD Billion)
  • Fig. 43 Canada clinical trial supplies market, 2018 - 2030 (USD Billion)
  • Fig. 44 Europe clinical trial supplies market, 2018 - 2030 (USD Billion)
  • Fig. 45 UK clinical trial supplies market, 2018 - 2030 (USD Billion)
  • Fig. 46 Germany clinical trial supplies market, 2018 - 2030 (USD Billion)
  • Fig. 47 France clinical trial supplies market, 2018 - 2030 (USD Billion)
  • Fig. 48 Italy clinical trial supplies market, 2018 - 2030 (USD Billion)
  • Fig. 49 Spain clinical trial supplies market, 2018 - 2030 (USD Billion)
  • Fig. 50 Denmark clinical trial supplies market, 2018 - 2030 (USD Billion)
  • Fig. 51 Sweden clinical trial supplies market, 2018 - 2030 (USD Billion)
  • Fig. 52 Norway clinical trial supplies market, 2018 - 2030 (USD Billion)
  • Fig. 53 Asia Pacific clinical trial supplies market, 2018 - 2030 (USD Billion)
  • Fig. 54 Japan clinical trial supplies market, 2018 - 2030 (USD Billion)
  • Fig. 55 China clinical trial supplies market, 2018 - 2030 (USD Billion)
  • Fig. 56 India clinical trial supplies market, 2018 - 2030 (USD Billion)
  • Fig. 57 Australia clinical trial supplies market, 2018 - 2030 (USD Billion)
  • Fig. 58 South Korea clinical trial supplies market, 2018 - 2030 (USD Billion)
  • Fig. 59 Thailand clinical trial supplies market, 2018 - 2030 (USD Billion)
  • Fig. 60 Latin America clinical trial supplies market, 2018 - 2030 (USD Billion)
  • Fig. 61 Brazil clinical trial supplies market, 2018 - 2030 (USD Billion)
  • Fig. 62 Mexico clinical trial supplies market, 2018 - 2030 (USD Billion)
  • Fig. 63 Argentina clinical trial supplies market, 2018 - 2030 (USD Billion)
  • Fig. 64 MEA clinical trial supplies market, 2018 - 2030 (USD Billion)
  • Fig. 65 South Africa clinical trial supplies market, 2018 - 2030 (USD Billion)
  • Fig. 66 Saudi Arabia clinical trial supplies market, 2018 - 2030 (USD Billion)
  • Fig. 67 UAE clinical trial supplies market, 2018 - 2030 (USD Billion)
  • Fig. 68 Kuwait clinical trial supplies market, 2018 - 2030 (USD Billion)